Your browser doesn't support javascript.
loading
The suggested chemopreventive association of metformin with prostate cancer in diabetic patients.
Goldberg, Hanan; Mohsin, Faizan K; Berlin, Alejandro; Chandrasekar, Thenappan; Wallis, Christopher J D; Klaassen, Zachary; Ahmad, Ardalan E; Saskin, Refik; Kenk, Miran; Saarela, Olli; Kulkarni, Girish S; Alibhai, Shabbir M H; Fleshner, Neil.
Afiliação
  • Goldberg H; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Urology, SUNY Upstate Medical Univers
  • Mohsin FK; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network; Department of Radiation Oncology, University of Toronto; and Techna Institute, University Health Network, Toronto, Ontario, Canada.
  • Chandrasekar T; Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia PA.
  • Wallis CJD; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada; Department of Urology, Vanderbilt University Medical Center, Nashville, TN.
  • Klaassen Z; Division of Urology, Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA; Georgia Cancer Center, GA.
  • Ahmad AE; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Saskin R; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Kenk M; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada.
  • Saarela O; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Kulkarni GS; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
  • Alibhai SMH; Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada.
  • Fleshner N; Division of Urology, Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, Ontario, Canada.
Urol Oncol ; 39(3): 191.e17-191.e24, 2021 03.
Article em En | MEDLINE | ID: mdl-32951988

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Complicações do Diabetes / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Complicações do Diabetes / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article